A 1-Month, Prospective, Multicenter, Open-Label Study of OTO-201 Given as a Single Administration for Treatment of Otitis Externa

Trial Profile

A 1-Month, Prospective, Multicenter, Open-Label Study of OTO-201 Given as a Single Administration for Treatment of Otitis Externa

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Nov 2016

At a glance

  • Drugs Ciprofloxacin (Primary)
  • Indications Otitis externa
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Otonomy
  • Most Recent Events

    • 03 Nov 2016 According to an Otonomy media release, results from this study were presented at the American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) 2016.
    • 13 Sep 2016 According to an Otonomy media release, data from this study will be presented at the American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) 2016.
    • 22 Jan 2016 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top